PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Gross Profit (2010 - 2012)

Updated

PharmaCyte Biotech's Gross Profit came in at $2,540 for FY2013 (year ended Apr 30, 2013), down 94.6% from $47,175 in FY2012.

Analysis

PharmaCyte Biotech (PMCB) Gross Profit (2010 - 2012) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Gross Profit at $47,175 in FY2012 (-49.8%) and $93,893 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 PharmaCyte Biotech 3.76 Mn -69.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -3,333.00
Jul 31, 2012 6,626.00
Apr 30, 2012 11,220.00
Jan 31, 2012 18,060.00
Oct 31, 2011 13,808.00
Jul 31, 2011 4,087.00
Apr 30, 2011 50,803.00
Jan 31, 2011 10,042.00
Oct 31, 2010 13,015.00
Jul 31, 2010 20,033.00
API Access

PharmaCyte Biotech Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=PMCB&period=max&api_key=YOUR_API_KEY